Isabelle Dussault

SVP, Research

Dr. Dussault was most recently global head of clinical biomarker strategy at EMD Serono, a subsidiary of Merck KGaA, where she oversaw clinical biomarker strategy for the entire portfolio. Prior to that, she was director of oncology research, tumor micro-environment and immuno-oncology at Bristol-Myers Squibb following her role as a director of ...


Roles at Fusion Pharmaceuticals

  • SVP, Research

    June, 2021 - present

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.